These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26935067)

  • 21. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.
    Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.
    Tran KT; Pallesen JS; Solbak SMØ; Narayanan D; Baig A; Zang J; Aguayo-Orozco A; Carmona RMC; Garcia AD; Bach A
    J Med Chem; 2019 Sep; 62(17):8028-8052. PubMed ID: 31411465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction.
    Wells G
    Biochem Soc Trans; 2015 Aug; 43(4):674-9. PubMed ID: 26551711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction.
    Colarusso S; De Simone D; Frattarelli T; Andreini M; Cerretani M; Missineo A; Moretti D; Tambone S; Kempf G; Augustin M; Steinbacher S; Munoz-Sanjuan I; Park L; Summa V; Tomei L; Bresciani A; Dominguez C; Toledo-Sherman L; Bianchi E
    Bioorg Med Chem; 2020 Nov; 28(21):115738. PubMed ID: 33065433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
    Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions.
    Jiang ZY; Lu MC; You QD
    J Med Chem; 2016 Dec; 59(24):10837-10858. PubMed ID: 27690435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
    Bhakkiyalakshmi E; Dineshkumar K; Karthik S; Sireesh D; Hopper W; Paulmurugan R; Ramkumar KM
    Bioorg Med Chem; 2016 Aug; 24(16):3378-86. PubMed ID: 27312421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
    Unni S; Deshmukh P; Krishnappa G; Kommu P; Padmanabhan B
    FEBS J; 2021 Mar; 288(5):1599-1613. PubMed ID: 32672401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism.
    Horie Y; Suzuki T; Inoue J; Iso T; Wells G; Moore TW; Mizushima T; Dinkova-Kostova AT; Kasai T; Kamei T; Koshiba S; Yamamoto M
    Commun Biol; 2021 May; 4(1):576. PubMed ID: 33990683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational cyclization-based minimization of entropy penalty upon the binding of Nrf2-derived linear peptides to Keap1: A new strategy to improve therapeutic peptide activity against sepsis.
    Chen K; Huang L; Shen B
    Biophys Chem; 2019 Jan; 244():22-28. PubMed ID: 30465941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a steady-state FRET-based assay to identify inhibitors of the Keap1-Nrf2 protein-protein interaction.
    Schaap M; Hancock R; Wilderspin A; Wells G
    Protein Sci; 2013 Dec; 22(12):1812-9. PubMed ID: 24130096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hit-to-Lead in Academia: Discovery of a Protein-Protein Interaction Inhibitor of Keap1-Nrf2].
    Yasuda D; Obata R; Takahashi K; Ohe T; Mashino T
    Yakugaku Zasshi; 2018; 138(8):1059-1065. PubMed ID: 30068847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction.
    Steel RJ; O'Connell MA; Searcey M
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2728-2731. PubMed ID: 29534931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissection of the role of p62/Sqstm1 in activation of Nrf2 during xenophagy.
    Ishimura R; Tanaka K; Komatsu M
    FEBS Lett; 2014 Mar; 588(5):822-8. PubMed ID: 24492006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization.
    Sogabe S; Sakamoto K; Kamada Y; Kadotani A; Fukuda Y; Sakamoto JI
    Biochem Biophys Res Commun; 2017 May; 486(3):620-625. PubMed ID: 28315327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Licochalcone A activates Keap1-Nrf2 signaling to suppress arthritis via phosphorylation of p62 at serine 349.
    Su X; Li T; Liu Z; Huang Q; Liao K; Ren R; Lu L; Qi X; Wang M; Chen J; Zhou H; Leung EL; Pan H; Liu J; Wang H; Huang L; Liu L
    Free Radic Biol Med; 2018 Feb; 115():471-483. PubMed ID: 29233793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy.
    Zhang W; Feng C; Jiang H
    Ageing Res Rev; 2021 Jan; 65():101207. PubMed ID: 33144123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitor.
    Yasuda D; Yuasa A; Obata R; Nakajima M; Takahashi K; Ohe T; Ichimura Y; Komatsu M; Yamamoto M; Imamura R; Kojima H; Okabe T; Nagano T; Mashino T
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5006-5009. PubMed ID: 29037947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
    Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
    Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1.
    Park JS; Kang DH; Lee DH; Bae SH
    Biochem Biophys Res Commun; 2015 Oct; 466(3):499-504. PubMed ID: 26381178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.